We aspire to be the premier research-intensive biopharmaceutical company in the world
For more than 125 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.
We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.
Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases.
Watch highlights of our discoveries and commitments from the start of our company to today.
Responsibility
The heart of our mission
We believe corporate responsibility is about our health, social, environmental and economic impact on people and communities around the world.
MSD has 2 sites in Belgium: 2 are located in Brussels - Watermael-Boitsfort & Schuman. The MSD site in Grand Duchy of Luxembourg is located in Windhof.
Anchored in Belgium & Luxembourg
At MSD Belgium & Luxembourg, more than 370 people work in national and international positions in various areas (as of 01/19). Belgium is one of more than 50 countries in which MSD conducts clinical research.
Research and Development
Manufacturing, Production and Quality Assurance
Marketing and Distribution
Human Resources, Supply Chain Management, Finance, IT
Serve patients in more than 140 countries
MSD
Our company has been active in Belgium since 1965 and is committed to strengthen health literacy and health economics, among other things. In 2018, MSD Belgium received the “Top Employer” and “Top Employer Europe” certifications for the third time in a row.
Our values
Our values represent the very core of our character. They guide every decision and action we take.
Patients first
Patients first
We are all accountable for delivering high-quality products and services. We aspire to improve the health and wellness of people and animals worldwide and to expand access to our medicines and vaccines. All of our actions must be measured against our responsibility to those who use or need our products.
Respect for people
Respect for people
Our ability to excel depends on the integrity, knowledge, imagination, skill, diversity, safety and teamwork of our employees. To this end, we work to create an environment of mutual respect, inclusion and accountability. We reward commitment and performance and are responsive to the needs of our employees and their families.
Ethics and integrity
Ethics and integrity
We are committed to the highest standards of ethics and integrity. We are responsible to our customers, to our competitors, to distributors and suppliers, to shareholders and to the communities we serve worldwide. In discharging our responsibilities, we do not take professional or ethical shortcuts.
Innovation and scientific excellence
Innovation and scientific excellence
We are dedicated to innovation and scientific excellence. Our research is guided by a commitment to improving health and quality of life. We strive to identify the most critical needs of patients and customers, and through continuous innovation, we challenge ourselves to meet those needs.
We’ve built a culture that embraces scientific excellence, operates with the highest standards of integrity, expands access to our products and employs a diverse workforce that values collaboration.
Meet our leaders at MSD BeLux: Rietja Hart, Finance Lead
We are continuing a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]
Next: Meet our leaders at MSD BeLux: Rietja Hart, Finance Lead
Katrien De Vos appointed to Managing Director, MSD Belgium & Luxembourg
Katrien De Vos has taken the lead of MSD Belgium & Luxembourg since Monday, May 1. In her new role of Managing Director, she takes over from An Cloet, External Affairs Director at MSD Belgium, who held the position ad interim for the past 6 months. Prior to joining MSD, Katrien De Vos held various […]
Next: Katrien De Vos appointed to Managing Director, MSD Belgium & Luxembourg
Meet our leaders at MSD BeLux: Dr. Laurent Viérin, Country Medical Director
We are starting a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]
Next: Meet our leaders at MSD BeLux: Dr. Laurent Viérin, Country Medical Director
Together against pneumococcal diseases
What are the numbers onhospitalisation and deaths? For adults above the age of 50, the chance at hospitalisation is lower in comparison to adults above the age of 65. Yet, pneumococcal diseases cause 5800 adults above the age of 50 to be hospitalised every year.2 As people get older, the chance of developing severe symptoms […]
Meet our leaders at MSD BeLux: Philippe Decerf, Business Operations Lead
We are starting a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]
Next: Meet our leaders at MSD BeLux: Philippe Decerf, Business Operations Lead
Meet our leaders at MSD BeLux: Rietja Hart, Finance Lead
We are continuing a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]
Next: Meet our leaders at MSD BeLux: Rietja Hart, Finance Lead
Katrien De Vos appointed to Managing Director, MSD Belgium & Luxembourg
Katrien De Vos has taken the lead of MSD Belgium & Luxembourg since Monday, May 1. In her new role of Managing Director, she takes over from An Cloet, External Affairs Director at MSD Belgium, who held the position ad interim for the past 6 months. Prior to joining MSD, Katrien De Vos held various […]
Next: Katrien De Vos appointed to Managing Director, MSD Belgium & Luxembourg
Meet our leaders at MSD BeLux: Dr. Laurent Viérin, Country Medical Director
We are starting a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]
Next: Meet our leaders at MSD BeLux: Dr. Laurent Viérin, Country Medical Director
Together against pneumococcal diseases
What are the numbers onhospitalisation and deaths? For adults above the age of 50, the chance at hospitalisation is lower in comparison to adults above the age of 65. Yet, pneumococcal diseases cause 5800 adults above the age of 50 to be hospitalised every year.2 As people get older, the chance of developing severe symptoms […]
Meet our leaders at MSD BeLux: Philippe Decerf, Business Operations Lead
We are starting a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]
Vaccines are one of the greatest public health success stories – and we’ve been discovering, developing and delivering vaccines to help prevent disease for over 100 years.
We play an important role in discovering and developing innovative medicines and vaccines to treat and prevent infectious diseases, including HIV and Ebola.
As a company dedicated to saving and improving lives, we have a special responsibility to help in the fight against COVID-19. We’ve been fully committed to developing an effective response to the COVID-19 pandemic since it was first recognized.